Atli, E., Kalkan, R., Mail, C. ., Eker, D. ., Demirci, U., Demir, S. ., Yalcintepe, S., Kirkizlar, H. O. ., Atli, E. ., Gurkan, H., & Demir, A. M. . (2021). THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES: Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies. Mediterranean Journal of Hematology and Infectious Diseases, 13(1), e2021013. https://doi.org/10.4084/mjhid.2021.013 (Original work published December 31, 2020)